Cargando…
A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348858/ https://www.ncbi.nlm.nih.gov/pubmed/35935608 http://dx.doi.org/10.1097/HS9.0000000000000757 |
| _version_ | 1784762004613890048 |
|---|---|
| author | Harrison, Claire Heidel, Florian H. Vannucchi, Alessandro M. Kiladjian, Jean-Jacques Hayat, Amjad Passamonti, Francesco Conneally, Eibhlin Kindler, Thomas Martino, Bruno Lipka, Daniel B. Stefanelli, Tommaso Roussou, Pantelia Germano, Davide Ewan, Jacqueline Ribrag, Vincent |
| author_facet | Harrison, Claire Heidel, Florian H. Vannucchi, Alessandro M. Kiladjian, Jean-Jacques Hayat, Amjad Passamonti, Francesco Conneally, Eibhlin Kindler, Thomas Martino, Bruno Lipka, Daniel B. Stefanelli, Tommaso Roussou, Pantelia Germano, Davide Ewan, Jacqueline Ribrag, Vincent |
| author_sort | Harrison, Claire |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9348858 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93488582022-08-05 A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis Harrison, Claire Heidel, Florian H. Vannucchi, Alessandro M. Kiladjian, Jean-Jacques Hayat, Amjad Passamonti, Francesco Conneally, Eibhlin Kindler, Thomas Martino, Bruno Lipka, Daniel B. Stefanelli, Tommaso Roussou, Pantelia Germano, Davide Ewan, Jacqueline Ribrag, Vincent Hemasphere Letter Lippincott Williams & Wilkins 2022-08-02 /pmc/articles/PMC9348858/ /pubmed/35935608 http://dx.doi.org/10.1097/HS9.0000000000000757 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter Harrison, Claire Heidel, Florian H. Vannucchi, Alessandro M. Kiladjian, Jean-Jacques Hayat, Amjad Passamonti, Francesco Conneally, Eibhlin Kindler, Thomas Martino, Bruno Lipka, Daniel B. Stefanelli, Tommaso Roussou, Pantelia Germano, Davide Ewan, Jacqueline Ribrag, Vincent A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_full | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_fullStr | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_full_unstemmed | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_short | A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis |
| title_sort | phase ib dose-finding study of panobinostat and ruxolitinib in myelofibrosis |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348858/ https://www.ncbi.nlm.nih.gov/pubmed/35935608 http://dx.doi.org/10.1097/HS9.0000000000000757 |
| work_keys_str_mv | AT harrisonclaire aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT heidelflorianh aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT vannucchialessandrom aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT kiladjianjeanjacques aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT hayatamjad aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT passamontifrancesco aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT conneallyeibhlin aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT kindlerthomas aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT martinobruno aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT lipkadanielb aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT stefanellitommaso aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT roussoupantelia aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT germanodavide aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT ewanjacqueline aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT ribragvincent aphaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT harrisonclaire phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT heidelflorianh phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT vannucchialessandrom phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT kiladjianjeanjacques phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT hayatamjad phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT passamontifrancesco phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT conneallyeibhlin phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT kindlerthomas phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT martinobruno phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT lipkadanielb phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT stefanellitommaso phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT roussoupantelia phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT germanodavide phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT ewanjacqueline phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis AT ribragvincent phaseibdosefindingstudyofpanobinostatandruxolitinibinmyelofibrosis |